iBio IBIO
NASDAQ IBIO
$1.17 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

iBio (IBIO) Current Debt (2023 - 2025)

Updated

iBio (IBIO) recorded Current Debt of $105,000 in fiscal Q1 2026 (quarter ended Sep 30, 2025).

Analysis

iBio (IBIO) Current Debt (2023 - 2025) Analysis & Trends

On a TTM basis, iBio's Current Debt came in at $796,000 as of Sep 30, 2025, up 15.2% year-over-year; for FY2024 (ended Jun 30, 2024), it was $895,000.

  • The fiscal Q1 2026 figure is the highest quarterly Current Debt since fiscal Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 208.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 37.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 64.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 iBio 121.75 Mn 121.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 105,000.00
Mar 31, 2024 691,000.00
Sep 30, 2023 204,000.00
API Access

iBio Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=IBIO&period=max&api_key=YOUR_API_KEY